You just read:

Luxcel Biosciences Ltd Announces World First Physiologically Relevant, In Vitro Ischemia-Reperfusion Model in Conjunction with BMG LABTECH and Ncardia

News provided by

Luxcel Biosciences Ltd

Sep 26, 2017, 08:40 ET